MAK218
Tace Inhibitor Screening Assay Kit
Sufficient for 100 Fluorometric tests
Synonym(s):
ADAM Metallopeptidase Domain 17, ADAM17 Inhibitor Screening Assay Kit, Tumor Necrosis Factor-α-converting enzyme Inhibitor Screening Kit
Sign Into View Organizational & Contract Pricing
All Photos(2)
About This Item
Recommended Products
detection method
fluorometric
storage temp.
−20°C
Gene Information
human ... ADAM17(6868)
mouse ... ADAM17(11491)
rat ... ADAM17(57027)
General description
Tumor necrosis factor-a converting enzyme (TACE; ADAM17) is a member of the ADAM (A Disintegrin And Metalloprotease) protein family implicated in cell-cell and cell-matrix interactions. TACE activates Notch signaling in the epidermal cells and has a critical function in the maintenance of barrier immunity. It is also involved in neurogenesis and muscle development.
Application
Tace Inhibitor Screening Assay Kit has been used in TACE (TNFa converting enzyme) activity assays.
Features and Benefits
Compatible with high-throughput handling systems.
Suitability
Suitable for the screening of inhibitors of TACE.
Principle
The TACE Inhibitor Screening Assay Kit is a rapid, simple and sensitive assay that is suitable for high throughput screening of TACE inhibitors. TACE hydrolyzes a FRET-tagged substrate to release a fluorescent product (λex = 318/ λem = 449 nm), proportional to the enzymatic activity present.
Kit Components Only
Product No.
Description
- TACE Assay Buffer
- TACE Substrate
- TACE Enzyme
- Inhibitor Control, 0.1 mM GM6001
Signal Word
Danger
Hazard Statements
Precautionary Statements
Hazard Classifications
Resp. Sens. 1
Storage Class Code
10 - Combustible liquids
WGK
WGK 3
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Joseph Dosch et al.
Oncotarget, 8(39), 65090-65099 (2017-10-17)
ADAM17 (a disintegrin and metalloproteinase 17)/TACE (TNFα converting enzyme) has emerged as a potential therapeutic target in colorectal cancer (CRC) and other cancers, due in part to its role in regulating various tumor cell surface proteins and growth factors and
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service